VIATRIS UK HEALTHCARE LIMITED
Get an alert when VIATRIS UK HEALTHCARE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-09-07 (in 4mo)
Last made up 2025-08-24
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£55M
+11% vs 2023
Employees
191
0% vs 2023
Profit before tax
£7M
-7.3% vs 2023
Name history
Renamed 2 times since incorporation
- VIATRIS UK HEALTHCARE LIMITED 2021-11-01 → present
- MYLAN UK HEALTHCARE LIMITED 2017-06-20 → 2021-11-01
- BGP PRODUCTS LTD. 2014-08-28 → 2017-06-20
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £276,728,000 | £268,817,000 | |
| Operating profit | £10,123,000 | £4,983,000 | |
| Profit before tax | £7,971,000 | £7,387,000 | |
| Net profit | £5,815,000 | £5,228,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £54,025,000 | £57,423,000 | |
| Net assets | £49,823,000 | £55,297,000 | |
| Equity | £49,823,000 | £55,297,000 | |
| Average employees | 191 | 191 | |
| Wages | £14,367,000 | £14,677,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 3.7% | 1.9% | |
| Net margin | 2.1% | 1.9% | |
| Return on capital employed | 18.7% | 8.7% | |
| Current ratio | 1.22x | 1.27x | |
| Interest cover | 4.95x | 1.64x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future, being at least 12 months from the date of approval of the financial statements. Accordingly, they continue to adopt the going concern basis in preparing the annual financial statements.”
Significant events
- “During the year, the company completed the divestiture of certain women's healthcare products to Exeltis UK Limited, an affiliate of Insud Pharma, S.L., a leading Spanish multinational pharmaceutical company.”
- “In July 2024, the company completed the divestiture of product rights for certain for over-the-counter (OTC) products lines to Cooper Consumer Health, a leading European OTC drug manufacturer and distributor.”
- “The OTC Transaction led to a net income of £5,948,000 in Viatris UK Healthcare in 2024 on the sale of the product rights.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BALCHIN, James Anthony | Director | 2025-10-31 | Jul 1988 | British |
| FISHER, Melissa | Director | 2024-03-08 | Dec 1972 | Irish |
| NARAYAN, Arun | Director | 2023-07-17 | Feb 1971 | French |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CORY, Rupert | Secretary | 2022-05-04 | 2025-10-31 |
| GOGAY, Kevan | Secretary | 2014-10-23 | 2015-02-27 |
| NUERNBERGER, Falk Patrick | Secretary | 2015-02-27 | 2022-05-04 |
| BIRBUET, Luis Rodolfo | Director | 2021-02-03 | 2023-07-17 |
| BRAULT, Jean-Yves | Director | 2014-12-02 | 2019-08-30 |
| CORY, Rupert | Director | 2020-03-09 | 2025-10-31 |
| COTARELO, Jose Javier | Director | 2019-08-22 | 2021-02-03 |
| DE LA MONTOISE, Betrand De Lavenne | Director | 2014-08-28 | 2014-10-22 |
| DIXON, Caroline Rebecca Louise | Director | 2016-02-02 | 2020-03-18 |
| FREYMAN, Thomas Craig | Director | 2014-08-28 | 2015-02-27 |
| GLINKA, Jacek | Director | 2015-02-27 | 2016-02-02 |
| PURI, Sandeep | Director | 2015-02-27 | 2016-02-02 |
| SALZMANN, Matthew | Director | 2021-02-03 | 2024-03-08 |
| SPARROW, Jamie | Director | 2016-02-02 | 2016-10-06 |
| WEITEKAMPER, Frank | Director | 2014-08-28 | 2015-02-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Viatris Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, voting-rights-75-to-100-percent-as-firm, Appoints directors | 2020-11-17 | Active |
| Mylan N.V. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-07-31 | Ceased 2020-11-17 |
| Mylan Holdings Ltd | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2020-07-31 |
Filing timeline
Last 20 of 79 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-07 | AA | accounts | Accounts with accounts type full | |
| 2025-10-31 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-31 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-10-31 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-25 | AAMD | accounts | Accounts amended with accounts type full | |
| 2025-02-19 | AA | accounts | Accounts with accounts type full | |
| 2024-08-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-15 | CH01 | officers | Change person director company with change date | |
| 2024-04-11 | AA | accounts | Accounts with accounts type full | |
| 2024-03-11 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-11 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-18 | AP01 | officers | Appoint person director company with name date | |
| 2023-07-18 | TM01 | officers | Termination director company with name termination date | |
| 2023-06-15 | AA | accounts | Accounts with accounts type full | |
| 2023-03-11 | DISS40 | gazette | Gazette filings brought up to date | |
| 2023-02-28 | GAZ1 | gazette | Gazette notice compulsory | |
| 2022-08-31 | AA | accounts | Accounts with accounts type full | |
| 2022-08-30 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-2.9%
£276,728,000 £268,817,000
-
Cash
—
Not reported
-
Net assets
+11%
£49,823,000 £55,297,000
-
Employees
0%
191 191
-
Operating profit
-50.8%
£10,123,000 £4,983,000
-
Profit before tax
-7.3%
£7,971,000 £7,387,000
-
Wages
+2.2%
£14,367,000 £14,677,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers